ADA Scientific Sessions 2025 Abstract
A Twelve-Week Trial of MET097—A Potent and Ultra-Long-Acting GLP-1 Receptor Agonist
Trial in peopleInterventions
Papers by Jason Mallory
2 results
- ADA Scientific Sessions 2025 Abstract
Safety, Tolerability, PK, and Efficacy of MET097—A Next-Generation Nutrient-Stimulated Hormone Peptide Analog for Chronic Weight Management
Trial in peopleInterventions